Génomic Vision SA EPS
¿Qué es el EPS de Génomic Vision SA?
El EPS de Génomic Vision SA es -0.10
¿Cuál es la definición de EPS?
Las ganancias por acción (EPS) son la parte de las ganancias de una empresa asignada a cada acción en circulación de acciones ordinarias. Se ajusta para la dilución y se calcula a lo largo de doce meses.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS de compañías en Sector Health Care en EURONEXT en comparadas con Génomic Vision SA
¿Qué hace Génomic Vision SA?
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Empresas con eps similar a Génomic Vision SA
- Mirasol Resources tiene EPS de -0.10
- Kovo HealthTech tiene EPS de -0.10
- Silver Bull Resources tiene EPS de -0.10
- Sandfire Resources tiene EPS de -0.10
- Winshine Science tiene EPS de -0.10
- FRNT tiene EPS de -0.10
- Génomic Vision SA tiene EPS de -0.10
- Barings Global Short Duration High Yield Fund tiene EPS de -0.10
- Numinus Wellness tiene EPS de -0.10
- Nuchev tiene EPS de -0.10
- Goodman Stapled Securities tiene EPS de -0.10
- Umiya Tubes tiene EPS de -0.10
- Auxly Cannabis tiene EPS de -0.10